Protease Inhibitor class drugs

5 results

  • evotaz

    (atazanavir and cobicistat)
    E.R. Squibb & Sons, L.L.C.
    EVOTAZ® is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents for adults and pediatric patients weighing at least 35 kg. Its use in treatment-experienced patients should be guided by baseline protease inhibitor resistance.
    Medication Details
    Drug Interactions

  • prezista

    (darunavir)
    Janssen Products LP
    PREZISTA, when co-administered with ritonavir and other antiretroviral agents, is indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 3 years and older.
    Medication Details
    Drug Interactions

  • reyataz

    (ATAZANAVIR)
    E.R. Squibb & Sons, L.L.C.
    REYATAZ® is indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 3 months and older who weigh at least 5 kg, in combination with other antiretroviral agents. It is not recommended for patients under 3 months due to the risk of kernicterus.
    Medication Details
    Drug Interactions